Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

Autor: Pfeifer, M, Zheng, B, Erdmann, T, Koeppen, H, McCord, R, Grau, M, Staiger, A, Chai, A, Sandmann, T, Madle, H, Dörken, B, Chu, Y-W, Chen, A I, Lebovic, D, Salles, G A, Czuczman, M S, Palanca-Wessels, M C, Press, O W, Advani, R, Morschhauser, F

Publikováno v: Leukemia (08876924); Jul2015, Vol. 29 Issue 7, p1578-1586, 9p, 1 Color Photograph, 2 Charts, 2 Graphs

Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview.

Autor: Argentiero, Antonella¹ (AUTHOR) a.argentiero@oncologico.bari.it, Andriano, Alessandro² (AUTHOR) a.andriano2@studenti.uniba.it, Marziliano, Donatello³ (AUTHOR) donatello.marziliano@uniba.it, Desantis, Vanessa² (AUTHOR) vanessa.desantis@uniba.it

Publikováno v: Hematology Reports. Mar2024, Vol. 16 Issue 1, p164-178. 15p.

B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.

Autor: Dai B; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.; Fachbereich Chemie und Pharmazie, University of Münster, Münster, Germany., Grau M; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Juilland M; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Klener P; Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.; Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic., Höring E; Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany., Molinsky J; Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.; Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic., Schimmack G; Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany., Aukema SM; Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany., Hoster E; Department of Internal Medicine III, Ludwig-Maximilians University Hospital Munich, Munich, Germany.; Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig-Maximilians University of Munich, Munich, Germany., Vogt N; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Staiger AM; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany.; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany., Erdmann T; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Xu W; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Erdmann K; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Dzyuba N; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Madle H; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany., Berdel WE; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Trneny M; Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic., Dreyling M; Department of Internal Medicine III, Ludwig-Maximilians University Hospital Munich, Munich, Germany., Jöhrens K; Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Lenz P; Department of Physics, Philipps University, Marburg, Germany., Rosenwald A; Department of Pathology, University of Würzburg, Würzburg, Germany., Siebert R; Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany.; Institute of Human Genetics, University Hospital Ulm, Ulm, Germany; and., Tzankov A; Institute of Pathology, University Hospital, Basel, Switzerland., Klapper W; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Anagnostopoulos I; Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Krappmann D; Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany., Ott G; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany., Thome M; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland., Lenz G; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.

Publikováno v: Blood [Blood] 2017 Jan 19; Vol. 129 (3), pp. 333-346. Date of Electronic Publication: 2016 Nov 18.

Generation of a Novel SORT1×HER2 Bispecific Antibody–Drug Conjugate Targeting HER2-Low-Expression Tumor.

Autor: Zhuang, Weiliang^1,2 (AUTHOR) bingdong09@163.com, Zhang, Wei² (AUTHOR) xieliping@sinopharm.com, Wang, Lei¹ (AUTHOR) lwangph@sjtu.edu.cn, Xie, Liping² (AUTHOR) fengjdmr@163.com, Feng, Jun² (AUTHOR), Zhang, Baohong¹ (AUTHOR) bhzhang@sjtu.edu.cn, Hu, Youjia² (AUTHOR) bhzhang@sjtu.edu.cn

Publikováno v: International Journal of Molecular Sciences. Nov2023, Vol. 24 Issue 22, p16056. 15p.

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects.

Autor: Karatrasoglou, Eleni A.¹ (AUTHOR) elinakar@med.uoa.gr, Dimou, Maria² (AUTHOR) msdimou@gmail.com, Piperidou, Alexia² (AUTHOR) alexia_piper@hotmail.com, Lakiotaki, Eleftheria¹ (AUTHOR) pkorkol@med.uoa.gr, Korkolopoulou, Penelope¹ (AUTHOR), Vassilakopoulos, Theodoros P.² (AUTHOR) theopvass@hotmail.com

Publikováno v: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14110. 18p.